Validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairment

Abstract Background In the present study, we examined the distinguishing ability of a mild cognitive impairment (MCI) assessment tool for rapid screening using a computer (MARC) for Alzheimer’s disease dementia (ADD), MCI, and non-demented controls (NDC) with no cognitive impairment, as well as its...

Full description

Bibliographic Details
Main Authors: Minoru Kouzuki, Madoka Miyamoto, Nobuto Tanaka, Katsuya Urakami
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Neurology
Subjects:
Online Access:https://doi.org/10.1186/s12883-022-02997-4
_version_ 1811188970649812992
author Minoru Kouzuki
Madoka Miyamoto
Nobuto Tanaka
Katsuya Urakami
author_facet Minoru Kouzuki
Madoka Miyamoto
Nobuto Tanaka
Katsuya Urakami
author_sort Minoru Kouzuki
collection DOAJ
description Abstract Background In the present study, we examined the distinguishing ability of a mild cognitive impairment (MCI) assessment tool for rapid screening using a computer (MARC) for Alzheimer’s disease dementia (ADD), MCI, and non-demented controls (NDC) with no cognitive impairment, as well as its validity and reliability, as part of a preliminary trial for the development of the tool. Methods A total of 64 participants (23 in the ADD group, 17 in the MCI group, and 24 in the NDC group) were analyzed. The participants were administered MARC and a pre-existing computerized Alzheimer’s dementia screening test (MSP), and 31 participants (14 in the MCI group, 17 in the NDC group) were readministered MARC within 4 months from the first test. Results The median (interquartile range) test time for MARC was 401 (350–453) s. Total MARC scores were significantly worse in the MCI and ADD groups than in the NDC group (p < 0.05 and p < 0.01, respectively). In the receiver operating characteristic (ROC) analysis, the area under the ROC curve (AUC) when comparing the NDC and MCI groups was 0.866 (95% CI, 0.759–0.974), when comparing the NDC and AD groups was 0.989 (95% CI, 0.970–1.000), and when comparing the MCI and AD groups was 0.889 (95% CI, 0.790–0.988). Furthermore, there was a significant correlation with the results of the existing test, MSP (r = 0.839, p < 0.001). In addition, the intraclass correlation coefficient (ICC) (1,1) when the first and second MARC scores were compared was 0.740 (95% CI, 0.529–0.865; p < 0.001). Conclusions MARC is considered capable of distinguishing MCI with high accuracy. The tool has good validity and reliability, and it can be administered in a short period of time without the need for a specialist.
first_indexed 2024-04-11T14:26:59Z
format Article
id doaj.art-d6c52d9282114f35aca1fa618f02ab7b
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-04-11T14:26:59Z
publishDate 2022-12-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-d6c52d9282114f35aca1fa618f02ab7b2022-12-22T04:18:48ZengBMCBMC Neurology1471-23772022-12-0122111010.1186/s12883-022-02997-4Validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairmentMinoru Kouzuki0Madoka Miyamoto1Nobuto Tanaka2Katsuya Urakami3Department of Biological Regulation, School of Health Science, Faculty of Medicine, Tottori UniversityDepartment of Dementia Prevention, School of Health Science, Faculty of Medicine, Tottori UniversityDepartment of Dementia Prevention, School of Health Science, Faculty of Medicine, Tottori UniversityDepartment of Dementia Prevention, School of Health Science, Faculty of Medicine, Tottori UniversityAbstract Background In the present study, we examined the distinguishing ability of a mild cognitive impairment (MCI) assessment tool for rapid screening using a computer (MARC) for Alzheimer’s disease dementia (ADD), MCI, and non-demented controls (NDC) with no cognitive impairment, as well as its validity and reliability, as part of a preliminary trial for the development of the tool. Methods A total of 64 participants (23 in the ADD group, 17 in the MCI group, and 24 in the NDC group) were analyzed. The participants were administered MARC and a pre-existing computerized Alzheimer’s dementia screening test (MSP), and 31 participants (14 in the MCI group, 17 in the NDC group) were readministered MARC within 4 months from the first test. Results The median (interquartile range) test time for MARC was 401 (350–453) s. Total MARC scores were significantly worse in the MCI and ADD groups than in the NDC group (p < 0.05 and p < 0.01, respectively). In the receiver operating characteristic (ROC) analysis, the area under the ROC curve (AUC) when comparing the NDC and MCI groups was 0.866 (95% CI, 0.759–0.974), when comparing the NDC and AD groups was 0.989 (95% CI, 0.970–1.000), and when comparing the MCI and AD groups was 0.889 (95% CI, 0.790–0.988). Furthermore, there was a significant correlation with the results of the existing test, MSP (r = 0.839, p < 0.001). In addition, the intraclass correlation coefficient (ICC) (1,1) when the first and second MARC scores were compared was 0.740 (95% CI, 0.529–0.865; p < 0.001). Conclusions MARC is considered capable of distinguishing MCI with high accuracy. The tool has good validity and reliability, and it can be administered in a short period of time without the need for a specialist.https://doi.org/10.1186/s12883-022-02997-4Mild cognitive impairmentAlzheimer’s disease dementiaComputerized cognitive assessment batteryNeuropsychological test
spellingShingle Minoru Kouzuki
Madoka Miyamoto
Nobuto Tanaka
Katsuya Urakami
Validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairment
BMC Neurology
Mild cognitive impairment
Alzheimer’s disease dementia
Computerized cognitive assessment battery
Neuropsychological test
title Validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairment
title_full Validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairment
title_fullStr Validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairment
title_full_unstemmed Validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairment
title_short Validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairment
title_sort validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairment
topic Mild cognitive impairment
Alzheimer’s disease dementia
Computerized cognitive assessment battery
Neuropsychological test
url https://doi.org/10.1186/s12883-022-02997-4
work_keys_str_mv AT minorukouzuki validationofanovelcomputerizedcognitivefunctiontestfortherapiddetectionofmildcognitiveimpairment
AT madokamiyamoto validationofanovelcomputerizedcognitivefunctiontestfortherapiddetectionofmildcognitiveimpairment
AT nobutotanaka validationofanovelcomputerizedcognitivefunctiontestfortherapiddetectionofmildcognitiveimpairment
AT katsuyaurakami validationofanovelcomputerizedcognitivefunctiontestfortherapiddetectionofmildcognitiveimpairment